FDA Approval of First Drug to Treat Tuberous Sclerosis Complex
Links shared publicly online about this topic.
- 763total visits
FDA Approval of First Drug to Treat Tuberous Sclerosis Complex
View full resource at disabled-world.com
Most Recently Shared on October 30, 2010 at 5:33 pm By:
FDA Approval of First Drug to Treat Tuberous Sclerosis Complex http://ff.im/-sUfnV
Novartis Gains FDA Approval for Afinitor As First New Treatment in Nearly Three Decades for Patients With Advanced Pancreatic NET
drugs.com — “Afinitor (everolimus) is used to treat advanced kidney cancer, subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis and pancreatic neuroendocrine tumors. Includes Afinitor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 7, 2011 at 5:12 am By:
Drugs and Devices OW OW Health
Novartis Gains FDA Approval for Afinitor As First New Treatment in Nearly Three Decades for Patients With ... http://bit.ly/kYPfZa #drug
FDA approves Afinitor drug for tuberous sclerosis complex
news-medical.net — “The Tuberous Sclerosis Alliance (TS Alliance) today announced the first drug approved for a tuberous sclerosis complex (TSC) indication by the Federal Drug Administration (FDA). This drug, manufactured by Novartis Oncology, is called Afinitor and will be used to treat subependymal giant cell astrocytomas (SEGAs) in individuals with TSC.” View full resource at news-medical.net
Most Recently Shared on November 1, 2010 at 6:16 am By:
News-Medical.Net Health News and Oncology
Oncology News: FDA approves Afinitor drug for tuberous sclerosis complex: The Tuberous Sclerosis Alliance (TS Alli... http://bit.ly/ceXube
Advertisement
